| Literature DB >> 24911446 |
Marieh Esmaeelpour1, Vedran Kajic2, Behrooz Zabihian2, Richu Othara2, Siamak Ansari-Shahrezaei3, Lukas Kellner3, Ilse Krebs3, Susanne Nemetz4, Martin F Kraus5, Joachim Hornegger5, James G Fujimoto6, Wolfgang Drexler2, Susanne Binder3.
Abstract
OBJECTIVES: To examine the feasibility of automatically segmented choroidal vessels in three-dimensional (3D) 1060-nmOCT by testing repeatability in healthy and AMD eyes and by mapping Haller's and Sattler's layer thickness in healthy eyes.Entities:
Mesh:
Year: 2014 PMID: 24911446 PMCID: PMC4050051 DOI: 10.1371/journal.pone.0099690
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Automatic segmentation of Haller's and Sattler's layer for thickness mapping.
OCT B-scan (A) visualizes the segmentation lines for the retina between the ILM (green line) and the RBC complex and the identified vessel voxels are visualized in red (B). The choroid is located between the RBC complex and the sclera (yellow line). Probability cones (small rectangle enlarged) were drawn to demonstrate expected vessel core position. The cone projections are in 3D, butthe concept is presented in two dimensions. The ratio of volume voxels to surface voxels that were generated was plotted for a 1×1 degree volume. This volume consists of 14 B-scans and is represented by the 5 B-scans in the yellow rectangle (C). The plot is used for determining the border between the two sublayers by detecting the largest ratio as Haller's layer vessels (H),and the local minimum is the border (arrow) to Sattler's layer (S). Plots were used to generate thickness maps for Sattler's (D) and Haller's layers (E) across the scan area.
Figure 2Repeatability of Sattler's and Haller's layer thickness mapping and ETDRS measurements in non-neovascular AMD.
Sattler's layer and Haller's layer are color mapped. Imaging was performed twice at the same session (left and middle column) and on a different day (right column). The vessel segmentation and indocyanine green angiography images of this eye are depicted in Figure 3.
Figure 3Segmentation validation in a non-neovascular AMD eye via a comparison of the segmented vasculature with indocyanine green angiography (ICGA).
Early phase (A) and middle phase (B) angiography images show the ICGAresolution for choroidal vascular imaging. OCT B-scan centered on the fovea (C), and segmented areasare marked in red (D) to visualize vessel segmentation. The OCT B-scan (D) shows the segmentation lines for the retina between the ILM (green line) and the RBC complex. The choroid is located between the RBC complex and the sclera (yellow line). En face views are locatedat the inner choroid (E), the outer choroid (F) and the entire choroid (G) to demonstrate captured vessels and depth information. The bars represent 1 mm.
Average repeated choroidalsublayer thickness measurements for the central submacular field (CSM) and the total macular field ( µm).
| Layer | R1 (range) | R2 (range) | R3 (range) |
| Δ R1-R2 (CI, LoA) | Δ R1-R3(CI, LoA) |
| Healthy | ||||||
| Sattler's (CSM) | 116±66(10–217) | 114±69(10–218) | 123±68(6–225) | .17 | 2 (−8–13, 59) | −7(−18–5, 64) |
| Sattler's (total) | 98±52(8–196) | 94±508–176) | 102±58(14–220) | .6 | 2 (−2–8, 32) | −4 (−12–2, 39) |
| Haller's (CSM) | 226±80 (89–348) | 228±86(87–361) | 216±85 (86–382) | .54 | 1(−6–7, 31) | −4(−24–16, 66) |
| Haller's (total) | 180±46(79–241) | 184±51(78–253) | 173±38 (63–228) | .2 | −4 (−12–4, 45) | 9(−13–30, 49) |
| Eyes with non-neovascular AMD | ||||||
| Sattler's (CSM) | 20±4(4–99) | 20±4(2–88) | 22±4 (5–133) | .61 | −1 (−0.8–1.4, 17) | −1 (−1.5–1, 6) |
| Sattler's (total) | 10±3(2–46) | 9±3(2–40) | 12±3(4–50) | .62 | −1 (−0.9–1.4, 6) | 0 (0−1, 5) |
| Haller's (CSM) | 139±45 (80–234) | 144±33 (82–233) | 149±38 (82–219) | .37 | −3(−14–9, 65) | −6 (−14–3, 50) |
| Haller's (total) | 95±27(61–147) | 93±27(57–151) | 90±21(62–133) | .37 | 2(−3–8, 31) | 3 (−5–10, 43) |
R1 and R2 represent imaging at the same session. R3 was performed on a different day. P values are stated for the difference between measurements by repeated measures ANOVA. Δ represents the difference. CI is the 95% confidence interval. LoA represents 95% limits of agreement. Data are expressed as the mean ± standard deviation.
Intraclass correlations (ICC) and coefficients of repeatability (CR).
| Layer | ICC R1-R2 (CI) | ICC R1-R3 (CI) | CR R1-R2 | CR R1-R3 |
| Healthy | ||||
| Sattler's (CSM) | 0.99 (0.96–1) | 0.95 (0.94–1) | 40 (35%) | 32 (27%) |
| Sattler's (total) | 0.96 (0.84–0.99) | 0.99 (0.96–1) | 22 (23%) | 26 (26%) |
| Haller's (CSM) | 0.99 (0.98–1) | 0.97 (0.88–0.99) | 22 (10%) | 46 (21%) |
| Haller's (total) | 0.99 (0.96–1) | 0.98 (0.89–0.99) | 32 (18%) | 33 (19%) |
| Non-neovascular AMD | ||||
| Sattler's (CSM) | 0.98 (0.93–0.99) | 0.86 (0.44–0.97) | 4 (20%) | 4 (20%) |
| Sattler's (total) | 0.95 (0.82–0.99) | 0.96 (0.86–0.99) | 4 (44%) | 4 (34%) |
| Haller's (CSM) | 0.9 (0.59-0-98) | 0.92 (0.69–0.98) | 44 (31%) | 34 (23%) |
| Haller's (total) | 0.97 (0.9–0.99) | 0.95 (0.80–0.99) | 21 (22%) | 19 (21%) |
R1 and R2 represent imaging at the same session. R3 was performed on a different day. CI is the 95% confidence interval. CR represents the coefficient of repeatability, expressed in parenthesis as the percentage of the mean difference.
Automated calculated mean for healthy Sattler's and Haller's layer thickness across the Early Treatment Diabetic Retinopathy Study grid ( µm).
| Subfield | Sattler's layer | Haller's layer |
| central submacular | 87±56 (3–264) | 141±50 (57–237) |
| superior inner | 77±51 (13–268) | 144±44 (65–251) |
| temporal inner | 71±52 (3–233) | 131±53 (48–255) |
| inferior inner | 77±55 (4–246) | 133±47 (48–225) |
| nasal inner | 81±60 (1–240) | 133±38 (58–211) |
| superior outer | 74±45 (10–243) | 121±33 (70–195) |
| temporal outer | 50±45 (4–213) | 103±40 (50–181) |
| inferior outer | 65±49 (5–215) | 117±37 (64–180) |
| nasal outer | 64±50 (3–203) | 110±35 (66–166) |
| Grouped by axial eye length for statistical analysis for the CSM subfielda | ||
| Hyperope n = 15 | 114±64 (3–264) | 168±43 (57–236) |
| Emmetrope n = 18 | 79±45 (19–165) | 133±46 (70–230) |
| Myope n = 12 | 48±35 (3–99) | 104±49 (50–236) |
|
| .006 (.004) | .003 (.002) |
| Grouped by age (years) for the CSM subfield | ||
| < 45 n = 27 | 91±51 | 144±50 |
| >45 n = 18 | 70±59 | 125±52 |
Data are expressed in µm and as the mean ± standard deviation (range).
a. Eyes were grouped based on the normal AL variation with refraction and age by myopia: AL≥24.5 mm, emmetropic: 24.5>AL≥23.4 mm or hyperopic:AL<23.4 mm)
b. univariate ANOVA (post-hoc test Tukey for hyperopic and myopic eyes)